203 related articles for article (PubMed ID: 19654065)
1. Seroprevalence of antibodies against fHbp and NadA, two potential vaccine antigens for Neisseria meningitidis.
Jacobsson S; Mölling P; Olcén P
Vaccine; 2009 Sep; 27(42):5755-9. PubMed ID: 19654065
[TBL] [Abstract][Full Text] [Related]
2. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.
Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS
J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.
de Voer RM; van der Klis FR; Nooitgedagt JE; Versteegh FG; van Huisseling JC; van Rooijen DM; Sanders EA; Berbers GA
Clin Infect Dis; 2009 Jul; 49(1):58-64. PubMed ID: 19480581
[TBL] [Abstract][Full Text] [Related]
4. Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriage.
Ala'aldeen DA; Flint M; Oldfield NJ; Omer SA; McNeil LK; Jiang Q; Murphy E; Giardina PC; Novikova EG; Dodge-Scully IL; Bayliss CD; Turner DP; Neal KR; Hoiseth SK; Jansen KU; Anderson AS
Vaccine; 2010 Nov; 28(48):7667-75. PubMed ID: 20875489
[TBL] [Abstract][Full Text] [Related]
5. A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups.
Hoiseth SK; Murphy E; Andrew L; Vogel U; Frosch M; Hellenbrand W; Abad R; Vazquez JA; Borrow R; Findlow J; Taha MK; Deghmane AE; Caugant DA; Kriz P; Musilek M; Mayer LW; Wang X; Macneil JR; York L; Tan CY; Jansen KU; Anderson AS
Pediatr Infect Dis J; 2013 Oct; 32(10):1096-101. PubMed ID: 23694830
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.
Wang X; Cohn A; Comanducci M; Andrew L; Zhao X; MacNeil JR; Schmink S; Muzzi A; Bambini S; Rappuoli R; Pizza M; Murphy E; Hoiseth SK; Jansen KU; Anderson AS; Harrison LH; Clark TA; Messonnier NE; Mayer LW
Vaccine; 2011 Jun; 29(29-30):4739-44. PubMed ID: 21571026
[TBL] [Abstract][Full Text] [Related]
7. Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1.
Brunelli B; Del Tordello E; Palumbo E; Biolchi A; Bambini S; Comanducci M; Muzzi A; Pizza M; Rappuoli R; Donnelly JJ; Giuliani MM; Serruto D
Vaccine; 2011 Jan; 29(5):1072-81. PubMed ID: 21130753
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
Trotter C; Findlow J; Balmer P; Holland A; Barchha R; Hamer N; Andrews N; Miller E; Borrow R
Clin Vaccine Immunol; 2007 Jul; 14(7):863-8. PubMed ID: 17494636
[TBL] [Abstract][Full Text] [Related]
9. A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines.
Koeberling O; Delany I; Granoff DM
Clin Vaccine Immunol; 2011 May; 18(5):736-42. PubMed ID: 21367981
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
[TBL] [Abstract][Full Text] [Related]
11. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis.
Scarselli M; Cantini F; Santini L; Veggi D; Dragonetti S; Donati C; Savino S; Giuliani MM; Comanducci M; Di Marcello F; Romagnoli G; Pizza M; Banci L; Rappuoli R
J Mol Biol; 2009 Feb; 386(1):97-108. PubMed ID: 19100746
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal carriage and immunity in western Burkina Faso, 2003.
Yaro S; Traoré Y; Tarnagda Z; Sangaré L; NjanpopLafourcade BM; Drabo A; Findlow H; Borrow R; Nicolas P; Gessner BD; Mueller JE
Vaccine; 2007 Sep; 25 Suppl 1():A42-6. PubMed ID: 17559988
[TBL] [Abstract][Full Text] [Related]
15. Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.
Backhouse JL; Gidding HF; MacIntyre CR; McIntyre PB; Gilbert GL
Vaccine; 2007 Jan; 25(7):1310-5. PubMed ID: 17069937
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of natural acquired antibodies to Haemophilus influenzae type b among children in Cairo-Egyptian.
Redwan el-RM; Elsawy A
Hum Antibodies; 2005; 14(1-2):23-6. PubMed ID: 16424597
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal protein antigens and vaccines.
Feavers IM; Pizza M
Vaccine; 2009 Jun; 27 Suppl 2():B42-50. PubMed ID: 19481315
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease.
Jacobsson S; Hedberg ST; Mölling P; Unemo M; Comanducci M; Rappuoli R; Olcén P
Vaccine; 2009 Mar; 27(10):1579-84. PubMed ID: 19162117
[TBL] [Abstract][Full Text] [Related]
19. Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen.
Vu DM; Wong TT; Granoff DM
Vaccine; 2011 Feb; 29(10):1968-73. PubMed ID: 21241734
[TBL] [Abstract][Full Text] [Related]
20. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
